Advertisement
Research Article

Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline

  • Susanta Mondal,

    Affiliation: Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America

    X
  • Jeffrey A. Martinson,

    Affiliation: Department of Immunology and Microbiology, Rush University Medical Center, Chicago, Illinois, United States of America

    X
  • Supurna Ghosh,

    Affiliation: Revalesio Corporation, Tacoma, Washington, United States of America

    X
  • Richard Watson,

    Affiliation: Revalesio Corporation, Tacoma, Washington, United States of America

    X
  • Kalipada Pahan mail

    Kalipada_Pahan@rush.edu

    Affiliation: Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America

    X
  • Published: December 20, 2012
  • DOI: 10.1371/journal.pone.0051869

Reader Comments (1)

Post a new comment on this article

Media Coverage of this Article

Posted by PLoS_ONE_Group on 04 Jan 2013 at 22:15 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: PR Newswire
Title: “Revalesio's RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice -- TACOMA, Wash., Jan. 3, 2013 /PRNewswire/ --”
http://www.prnewswire.com...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff

RE: Media Coverage of this Article

PLoS_ONE_Group replied to PLoS_ONE_Group on 18 Jan 2013 at 23:21 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: Multiple Sclerosis Research Blog
Title: “Multiple Sclerosis Research: Research: Is a salt tablet going to treat MS make way for super saline”
http://multiple-sclerosis...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff

RE: Media Coverage of this Article

PLoS_ONE_Group replied to PLoS_ONE_Group on 15 Nov 2013 at 22:26 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: PR Newswire
Title: “Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University... -- TACOMA, Wash., Nov. 11, 2013 /PRNewswire/ --”
http://www.prnewswire.com...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff